Skip to main content

Advertisement

SpringerLink
Log in

Insulin-like growth factor-1 and soluble FMS-like tyrosine kinase-1 prospectively predict cancelled IVF cycles

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To identify biomarkers that prospectively predict IVF cycle cancellation.

Methods

In this prospective study, sera were obtained prior to any intervention, from women about to undergo an IVF cycle. The sera were assayed by ELISA for levels of insulin-like growth factor (IGF)-1, IGF-2, IGF binding protein (BP)-1, and soluble fms-like tyrosine kinase (sFLT-1). The cancellation or progression of the IVF cycle was subsequently obtained by chart review. Associations between serum components and outcome were analyzed by the Mann-Whitney test. Receiver operator curves were constructed to evaluate the strength of the correlations between biomarkers and cycle cancellation, as assessed from the area under the curve (AUC).

Results

A total of 205 women were included. Twenty-seven (13.2%) cycle cancellations due to poor response were recorded. Women with a cancelled cycle had reduced anti-Mullerian hormone (AMH) values (p < 0.001) and antral follicle count (p = 0.003). There were no significant differences between the two groups with regard to age and BMI. Median concentrations of IGF-1 and sFLT-1 were elevated in sera from women whose IVF cycles were cancelled as compared to those with ongoing cycles (p = 0.015 and p < 0.001, respectively); AUC for IGF-1 and sFLT-1 were 0.67 and 0.75, respectively. Concentrations of sFLT-1 remained significantly higher in patients with cancelled cycles even after controlling for AMH levels. There were no differences in IGF-2 and IGFBP-1 levels between the two groups.

Conclusions

Measurement of circulating IGF-1 and sFLT-1 levels prior to initiation of an IVF cycle has the potential to identify women whose cycles have an increased likelihood to be subsequently cancelled.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Badawy A, Wageah A, El Gharib M, Osman EE. Prediction and diagnosis of poor ovarian response: the dilemma. J Reprod Infertil. 2011;12(4):241–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Garcia JE, Jones GS, Acosta AA, Wright G. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981. Fertil Steril. 1983;39:167–73.

    Article  CAS  Google Scholar 

  3. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril. 1988;50:298–307.

    Article  CAS  Google Scholar 

  4. Sharif K, Elgendy M, Lashen H, Afnan M. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol. 1998;105:107–12.

    Article  CAS  Google Scholar 

  5. Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN, Yang YS. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril. 2003;79:63–8.

    Article  Google Scholar 

  6. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685–718.

    Article  CAS  Google Scholar 

  7. Sills ES, Alper MM, Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):30–6. https://doi.org/10.1016/j.ejogrb.2009.05.008.

    Article  PubMed  Google Scholar 

  8. La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;1:124–40.

    Article  Google Scholar 

  9. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;6:685–718.

    Article  Google Scholar 

  10. Oosterhuis GJE, Vermes I, Lambalk CB, Michegelsen HWB, Shoemaker J. Insulin-like growth (IGF)-I and IGF binding protein-3 concentration in fluid from human stimulated follicles. Hum Reprod. 1998;13:285–9.

    Article  CAS  Google Scholar 

  11. Dor J, Ben-Shlomo I, Lunenfeld B. Insulin-like growth factor-I (IGF-I) may not be essential for ovarian follicular development: evidence from IGF-I deficiency. J Clin Endocrinol Metab. 1992;74:539–42.

    CAS  PubMed  Google Scholar 

  12. Schoyer KD, Liu HC, Witkin S, Rosenwacks Z, Spandorfer SD. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome. Fertil Steril. 2007;88:139–44.

    Article  CAS  Google Scholar 

  13. Choi YS, Kim SH, Ki SY, et al. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients. Gynecol Obstet Invest. 2009;67:73–80.

    Article  CAS  Google Scholar 

  14. Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F, Bernabeu R, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002;17:1017–22.

    Article  CAS  Google Scholar 

  15. Dorn C, Reinsberg J, Kupka M, van der Ven H, Schild RL. Leptin, VEGF, IGF-1 and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization. Arch Gynecol Obstet. 2003;268:187–93.

    Article  CAS  Google Scholar 

  16. Ramer I, Kanninen TT, Sisti G, Witkin SS, Spandorfer SD. Association of in vitro fertilization outcome with circulating insulin-like growth factor components prior to cycle initiation. Am J Obstet Gynecol. 2015;213:356.e1–6.

    Article  CAS  Google Scholar 

  17. Han VKM, Bassett N, Walton J, Challis JRG. The expression of insulin-like growth factor (IGF) and IGF binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab. 1996;81:2680–93.

    CAS  PubMed  Google Scholar 

  18. Pringle KG, Roberts CT. New light on early post-implantation pregnancy in the mouse: roles for insulin-like growth factor-II (IGF II)? Placenta. 2006;28:286–97.

    Article  Google Scholar 

  19. Irving JA, Lala PK. Cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res. 1995;217:419–27.

    Article  CAS  Google Scholar 

  20. Irwin JC, Giudice LC. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast a5b1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res. 1998;8:21–31.

    Article  CAS  Google Scholar 

  21. Kawano Y, Narahara H, Matsui N, Nasu K, Miyamura K, Miyakawa I. Insulin-like growth factor-binding protein-1 in human follicular fluid: a marker of oocyte maturation. Gynecol Obstet Invest. 1997;44:145–8.

    Article  CAS  Google Scholar 

  22. Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Regulation of vascular endothelial factor-A and its soluble receptor sFLT-1 by luteinizing hormone in vivo: Implication for ovarian follicle angiogenesis. Fertil Steril. 2008;89:922–6.

    Article  CAS  Google Scholar 

  23. Vural F, Vural B, Doger E, Cakiroglu Y, Cekmen M. Perifollicular blood flow and its relationship with endometrial vascularity, follicular fluid EG-VEGF, IGF-1, and inhibin-a levels and IVF outcomes. J Assist Reprod Genet. 2016;33:1355–62.

    Article  Google Scholar 

  24. Davoren JB, Kasson BG, Li CH, Hsueh AJW. Specific insulin-like growth factor I– and II–binding sites on rat granulosa cells: relation to IGF action. Endocrinology. 1986;119:2155–62.

    Article  CAS  Google Scholar 

  25. Adashi EY. The ovarian follicle: life cycle of a pelvic clock. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology, vol. 1. Philadelphia: Lippincott-Raven; 1996. p. 211–34.

    Google Scholar 

  26. Davoren JB, Hsueh AJW, Li CH. Somatomedin C augments FSH-induced differentiation of cultured rat granulose cells. Am J Physiol. 1985;249:E26–33.

    CAS  PubMed  Google Scholar 

  27. Adashi EY, Resnick CE, D’Ercole AJ, Svoboda ME, Van Wyk JJ. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev. 1985;6:400–20.

    Article  CAS  Google Scholar 

  28. Chun SY, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsue AJ. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology. 1994;135:1845–53.

    Article  CAS  Google Scholar 

  29. Eden JA, Jones J, Carter GD, Alaghband-Zadeh J. A comparison of follicular fluid levels of insulin-like growth factor-1 in normal dominant and cohort follicles, polycystic and multicystic ovaries. Clin Endocrinol. 1988;29:327–36.

    Article  CAS  Google Scholar 

  30. Rabinovici J, Dandekar P, Angle MJ, Rosenthal S, Martin MC. Insulin like growth factor I (IGF-I) levels in follicular fluid from human revelatory follicles: correlation with serum IGF-I levels. Fertil Steril. 1990;54:428–33.

    Article  CAS  Google Scholar 

  31. Huang JY, Rosenwaks Z. Assisted reproductive techniques. Methods Mol Biol. 2014;1154:171–231.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital of the University of Pennsylvania, Helen O’Dickens Women’s Health Center, 3400 Spruce St, Philadelphia, PA, 19104, USA

    Dimitrios Nasioudis

  2. Weill Cornell Medicine, 1300 York avenue, New York, NY, 10021, USA

    Evelyn Minis, Fabiana Kreines & Steven S. Witkin

  3. Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, 1305 avenue, York, 10021, USA

    Mohamad Irani & Steven D. Spandorfer

Authors
  1. Dimitrios Nasioudis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evelyn Minis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamad Irani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fabiana Kreines
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Steven S. Witkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steven D. Spandorfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven D. Spandorfer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

“All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (include name of committee + reference number) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”

Informed consent

“Informed consent was obtained from all individual participants included in the study.”

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dimitrios Nasioudis and Evelyn Minis are first co-authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nasioudis, D., Minis, E., Irani, M. et al. Insulin-like growth factor-1 and soluble FMS-like tyrosine kinase-1 prospectively predict cancelled IVF cycles. J Assist Reprod Genet 36, 2485–2491 (2019). https://doi.org/10.1007/s10815-019-01618-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-019-01618-3

Keywords

Search

Navigation